Tango Therapeutics (TNGX) Non-Current Deferred Revenue (2020 - 2025)
Tango Therapeutics (TNGX) recorded Non-Current Deffered Revenue of $30.44 million in Q2 2025, down 44.1% from $54.44 million a year earlier and down 18.9% from the prior quarter.
Tango Therapeutics (TNGX) Non-Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Tango Therapeutics reported Non-Current Deffered Revenue of $44.77 million, down 32.9% from FY2023.
- Annual Non-Current Deffered Revenue has declined for four straight years, with a four-year compound annual growth rate of -22.0% (FY2020 to FY2024).
- Across earlier years, Non-Current Deffered Revenue came in at $66.68 million in FY2023 (-27.6%), $92.09 million in FY2022 (-19.7%), $114.72 million in FY2021 (-5.0%) and $120.81 million in FY2020.
- The Q2 2025 figure is the lowest quarterly Non-Current Deffered Revenue since Q2 2021.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for 12 consecutive quarters, with an average decline of 31.8% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 5.0% (Q4 2021) to 44.1% (Q2 2025).
- Per Business Quant, the preceding three quarters came in at $37.51 million (Q1 2025), $44.77 million (Q4 2024) and $50.9 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Tango Therapeutics | 4.12 Bn | 1.40 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 30.44 Mn |
| Mar 31, 2025 | 37.51 Mn |
| Dec 31, 2024 | 44.77 Mn |
| Sep 30, 2024 | 50.90 Mn |
| Jun 30, 2024 | 54.44 Mn |
| Mar 31, 2024 | 62.81 Mn |
| Dec 31, 2023 | 66.68 Mn |
| Sep 30, 2023 | 70.71 Mn |
| Jun 30, 2023 | 74.67 Mn |
| Mar 31, 2023 | 84.10 Mn |
| Dec 31, 2022 | 92.09 Mn |
| Sep 30, 2022 | 99.82 Mn |
| Jun 30, 2022 | 105.01 Mn |
| Mar 31, 2022 | 111.96 Mn |
| Dec 31, 2021 | 114.72 Mn |
| Sep 30, 2021 | 116.65 Mn |
| Jun 30, 2021 | 5.84 Mn |
| Mar 31, 2021 | 5.84 Mn |
| Dec 31, 2020 | 120.81 Mn |
| Sep 30, 2020 | 5.84 Mn |
Tango Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TNGX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TNGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TNGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();